Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan 1;5(1):129-35.
doi: 10.1177/193229681100500118.

Guidelines for optimal bolus calculator settings in adults

John Walsh  1 , Ruth Roberts, Timothy Bailey
Affiliations
Review

Guidelines for optimal bolus calculator settings in adults

John Walsh et al. J Diabetes Sci Technol. .

Abstract

Bolus insulin calculators (BCs) became available in insulin pumps in 2002 and are being integrated into glucose meters and portable device applets for use with multiple daily injections. A retrospective analysis of continuous subcutaneous insulin infusion data from the Actual Pump Practices (APP) study is used in this article to generate formulas for more precise BC settings. A well-designed BC determines accurate bolus doses for carbohydrate intake and for correcting elevated glucose levels. It should also provide the logic necessary to track residual bolus insulin and reduce bolus recommendations to minimize insulin stacking. To provide appropriate bolus doses, a BC requires accurate settings for the carbohydrate factor or insulin:carbohydrate ratio, glucose correction factor, duration of insulin action, and correction target. We provide guidelines to select BC settings from the user's current total daily dose (TDD) of insulin and to determine more appropriate BC settings from an improved TDD based on the mean glucose level.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Physiodynamics in nondiabetic subjects not equivalent to DIA.
See this image and copyright information in PMC

References

    1. Walsh J, Roberts R, Bailey T. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol. 2010;4(5):1174–1181. - PMC - PubMed
    1. Del Sindaco P, Ciofetta M, Lalli C, Perriello G, Pampanelli S, Torlone E, Brunetti P, Bolli GB. Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med. 1998;15(7):592–600. - PubMed
    1. Davidson PC, Hebblewhite HR, Bode BW, Steed RD, Welch NS, Greenlee MC, Richardson PL, Johnson J. Statistically based CSII parameters: correction factor, CF (1700 rule), carbohydrate-to-insulin ratio, CIR (2.8 rule), and basal-to-total ratio. Diabetes Technol Ther. 2003;3:237–242.
    1. Garg SK, Rosenstock J, Ways K. Optimized basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with basal insulin glargine. Endocr Pract. 2005;11(1):11–17. - PubMed
    1. Walsh J, Wroblewski D, Bailey TS. Disparate bolus on board recommendations in insulin pump therapy. AACE meeting; 2007; poster.